Anika Therapeutics ANIK Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $112.82M-6.9% | $121.2M-27.3% | $166.66M+6.7% | $156.24M+5.7% | ||
| $112.82M-6.9% | $121.2M-27.3% | $166.66M+6.7% | $156.24M+5.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Anika Therapeutics's revenue?
- Anika Therapeutics (ANIK) generated $116.3M in revenue over the trailing twelve months, up 8.8% year over year.
- Is Anika Therapeutics profitable?
- Anika Therapeutics is not currently profitable: it reported a net loss of $11.4M over the trailing twelve months, a -9.8% net margin.
- Where does Anika Therapeutics's income statement data come from?
- Every line is extracted from Anika Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
